Diligence memo · auto-generated · as of July 2, 2026

Ambra Bioscience LLC

Ambra Bioscience LLC has raised $3.8M over 4 rounds; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Ambra Bioscience LLC operates in Biotech, based in San Diego.

Sub-sector tags: biotech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Ambra Bioscience LLC has raised $3.8M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.2M on 2015-01-16.

Most recent recorded round closed around 2017-11-16.

Valuation (modeled)modeled

Provath models Ambra Bioscience LLC at approximately $47M (range $756K–$366M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 8.6 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 77% of Biotech peers (233 compared).

Modeled value ranks above 82% of those peers.

Closest niche peers: Cen Biotech Inc.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.